anti-Human CD55 antibody for Functional Studies

Recommended CD55 Antibody (supplied by: Log in to see )

Antigen
Complement Decay-Accelerating Factor (CD55) Antibodies
  • Daf
  • Daf-GPI
  • Daf1
  • GPI-DAF
  • CR
  • CROM
  • DAF
  • TC
  • AI323748
  • Cd55b
  • Daf-TM
  • TM-DAF
  • CD55 antigen
  • CD55 molecule, decay accelerating factor for complement (Cromer blood group)
  • decay accelerating factor 2
  • Cd55
  • CD55
  • Daf2
Reactivity
Human
423
65
22
9
9
4
3
2
2
2
Host
Mouse
346
100
32
8
7
4
3
Clonality
Monoclonal
Conjugate
This CD55 antibody is un-conjugated
53
47
30
15
13
13
12
9
8
8
6
6
6
6
6
6
6
6
6
5
5
5
3
3
2
2
1
1
1
Application
Functional Studies (Func), Flow Cytometry (FACS), Immunoprecipitation (IP), Western Blotting (WB)
376
189
97
65
58
54
41
40
12
11
6
6
5
5
3
2
1
1
1
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

Submit your validation data for this product and get a full refund. I want to validate this product

Learn more

Catalog No. ABIN2480961
$ 407.65
Plus shipping costs $45.00
Relevance Score ABIN Application Conjugate Host Isotype Epitope Supplier Clonality References Details
1 ABIN260409 Func FACS IP WB Mouse IgG1 Log in to see BRIC216
1 ABIN2136863 Func FACS IP IHC WB Mouse IgG1 kappa Log in to see 143-30

General

Antigen Complement Decay-Accelerating Factor (CD55) Antibodies
Reactivity Human
(423), (65), (22), (9), (9), (4), (3), (2), (2), (2)
Host Mouse
(346), (100), (32), (8), (7), (4), (3)
Clonality (Clone)
Monoclonal   ( )
Conjugate This CD55 antibody is un-conjugated
(53), (47), (30), (15), (13), (13), (12), (9), (8), (8), (6), (6), (6), (6), (6), (6), (6), (6), (6), (5), (5), (5), (3), (3), (2), (2), (1), (1), (1)
Application Functional Studies (Func), Flow Cytometry (FACS), Immunoprecipitation (IP), Western Blotting (WB)
(376), (189), (97), (65), (58), (54), (41), (40), (12), (11), (6), (6), (5), (5), (3), (2), (1), (1), (1), (1), (1)
Pubmed 4 references available
Supplier Log in to see

Product Details anti-CD55 Antibody

Target Details CD55 Application Details Handling References for anti-CD55 antibody (ABIN2480961) Images
Characteristics Purified IgG
Purification Purified
Immunogen Human fibroblast cell line
Clone BRIC216
Isotype IgG1

Target Details CD55

Product Details anti-CD55 Antibody Application Details Handling References for anti-CD55 antibody (ABIN2480961) Images back to top
Antigen
Alternative Name CD55 (CD55 Antibody Abstract)
Background Synonyms: DAF
Gene ID 1604
UniProt P08174
Research Area Immunology, CD Antigens, Surface Receptors of Immune Cells
Pathways Complement System, Regulation of Leukocyte Mediated Immunity

Application Details

Product Details anti-CD55 Antibody Target Details CD55 Handling References for anti-CD55 antibody (ABIN2480961) Images back to top
Application Notes Optimal working dilution should be determined by the investigator.
Restrictions For Research Use only

Handling

Product Details anti-CD55 Antibody Target Details CD55 Application Details References for anti-CD55 antibody (ABIN2480961) Images back to top
Format Liquid
Concentration 1.0 mg/mL

References for anti-CD55 antibody (ABIN2480961)

Product Details anti-CD55 Antibody Target Details CD55 Application Details Handling Images back to top
Product cited in:

Loberg, Day, Dunn, Kalikin, Pienta: "Inhibition of decay-accelerating factor (CD55) attenuates prostate cancer growth and survival in vivo." in: Neoplasia (New York, N.Y.), Vol. 8, Issue 1, pp. 69-78, 2006

Liszewski, Leung, Schraml, Goodship, Atkinson: "Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome." in: Molecular immunology, Vol. 44, Issue 7, pp. 1559-68, 2006

Background publications

Coyne, Hall, Thompson, Arce, Kinoshita, Fujita, Anstee, Rosse, Lublin: "Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 149, Issue 9, pp. 2906-13, 1992

Anderson, Briefel, Jones, Ryu, McGuire, Yun: "Effects of acetate dialysate on transforming growth factor beta 1, interleukin, and beta 2-microglobulin plasma levels." in: Kidney international, Vol. 40, Issue 6, pp. 1110-7, 1992